Pharmas will need to provide their latest stance on the Most Favored Nation drug pricing plans, while biotech finally gets a ...
InvestorsHub on MSN
Aquestive shares slide after FDA flags issues in Anaphylm filing
Aquestive Therapeutics (NASDAQ:AQST) saw its shares plunge about 40% on Friday after the company said the U.S. Food and Drug ...
Qure N.V. (NASDAQ:QURE) surged around 15% in early trading on Friday after the company said it has secured a Type A meeting ...
Each week, our team shares the latest recall alerts from sources such as the U.S. Food & Drug Administration (FDA), the U.S.
Given the FDA’s decision to initiate the removal of boxed warning labels from hormone therapy products, it may be prescribed ...
Marks a world-first as Regentis uses MOCART, a quantitative standard to measure regeneration of cartilage in a clinical ...
Crofelemer has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) and the European Medicines ...
Silicone’s composition gives it a synthetic polymer structure with a silicon-oxygen backbone, making it more resistant to ...
A successful Phase 3 trial and a public offeringof stock boosted prospects for this company to receive approval for an ...
The Ambriola Company issued a recall for its pecorino Romano cheese products in November over a potential listeria ...
MoonLake regains momentum after the FDA Type B meeting allows BLA submission for sonelokimab in HS without additional trials.
The post Nicotine’s comeback is the latest wellness scam appeared first on Salon.com.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results